Abstract:Synergistic therapeutic effect through the intracellular co-delivery of chemotherapy and biomacromolecule drugs is a novel strategy for improving tumor treatment effectiveness. A triblock copolymer, poly(acrylic acid)-poly(N, N-diisopropylaminoethyl methacrylate)-poly(N-vinylcaprolactam) (PAA-PDPA-PNVCL), was designed and synthesized for the construction of smart responsive drug carriers. The structure of the polymers was verified by nuclear magnetic resonance spectroscopy (1H-NMR) and fluorescence spectrophotometer (FL). The transmittances of the polymer solutions under different pH values or temperatures were measured by ultraviolet-visible spectroscopy (UV-Vis). Results showed that the polymer had excellent pH responsiveness and a low critical solution temperature (LCST), which could self-assemble into vesicles with PAA as hydrophilic shell, PDPA as hydrophobic intermediate layer and PNVCL as hydrophilic cavity. Then, the PAA shell layer was crosslinked with disulfide bonds through amide reaction, to improve the structural stability of vesicles and meanwhile introduce the reduction sensitivity. The changes of the particle size, Zeta potential, and morphology of the vesicle under different conditions were studied by dynamic light scattering (DLS) and transmission electron microscopy (TEM). Results showed that the shell-crosslinked vesicles were uniformly sized spherical structure with good pH value and reduction responsiveness. Their drug encapsulation effect and in-vitro release behavior under different pH values and glutathione (GSH) concentrations were studied by UV-Vis and FT-IR. Results showed that the carriers could achieve zoned and co-loading of hydrophobic small molecule drug (doxorubicin (DOX)) and hydrophilic macromolecular protein drug model (bovine serum protein (BSA)). The hydrophobic layer of PDPA and the crosslinked layer of PAA provided dual-blockade for drug leakage. The leakage of drugs under normal physiological conditions was low, and the release of DOX and BSA could only be triggered under simulated tumor microenvironment, that is, weak acid and high concentration of GSH conditions. The smart responsive drug carriers constructed in this paper are expected to achieve co-delivery of chemotherapy and biomacromolecule drugs, which have potential application value to the clinical treatment of tumors.

A General "Two-Lock" Strategy to Enhance Drug Loading and Lysosomal Escape in Intelligent Boronate Ester Polymer Nanoparticles for Improved Chemotherapy

Bilayer nanocarrier with protein-acid conjugation for prolonged release and enhanced anticancer effects.

Nanodelivery of a Self-Assembling Prodrug with Exceptionally High Drug Loading Potentiates Chemotherapy Efficacy.

A facile strategy for constructing boron-rich polymer nanoparticles via a boronic acid-related reaction

Multi-Stimuli-Responsive Nanoparticles Formed of POSS-PEG for the Delivery of Boronic Acid-Containing Therapeutics.

Phenylboronic Acid Modification Augments the Lysosome Escape and Antitumor Efficacy of a Cylindrical Polymer Brush-Based Prodrug

Engineered Borate Ester Conjugated Protein-Polymer Nanoconjugates for Ph-Responsive Drug Delivery.

A Facile Strategy for PEGylated Nanoprodrug of Bortezomib with Improved Stability, Enhanced Biocompatibility, pH-Controlled Disassembly, and Release

High drug loading and pH-responsive nanomedicines driven by dynamic boronate covalent chemistry for potent cancer immunotherapy

The Combined Effects of Size and Surface Chemistry on the Accumulation of Boronic Acid-Rich Protein Nanoparticles in Tumors.

Boron Neutron Capture Therapy Enhanced by Boronate Ester Polymer Micelles: Synthesis, Stability, and Tumor Inhibition Studies

Phenylboronic Acid-Decorated Gelatin Nanoparticles for Enhanced Tumor Targeting and Penetration.

Dual-Responsive Polymer Vesicles Capable of Co-loading Two Antitumor Drugs

Polymeric Micelles with Endosome Escape and Redox-Responsive Functions for Enhanced Intracellular Drug Delivery

Phenylboronic Acid-Functionalized Copolypeptides: Facile Synthesis and Responsive Dual Anticancer Drug Release

Dual stimuli-responsive dendronized prodrug derived from poly(oligo-(ethylene glycol) methacrylate)-based copolymers for enhanced anti-cancer therapeutic effect

Enhancing Cancer Therapy: Boron-Rich Polyboronate Ester Micelles for Synergistic Boron Neutron Capture Therapy and PD-1/PD-L1 Checkpoint Blockade

Stable Polymer Nanoparticles with Exceptionally High Drug Loading by Sequential Nanoprecipitation

Structure‐Based Rational Design of Prodrugs to Enable Their Combination with Polymeric Nanoparticle Delivery Platforms for Enhanced Antitumor Efficacy

Dendritic Nanomedicine with Boronate Bonds for Augmented Chemo‐immunotherapy via Synergistic Modulation of Tumor Immune Microenvironment

An Orthogonal Protection Strategy for Synthesizing Scaffold-Modifiable Dendrons and Their Application in Drug Delivery